These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1821629)
1. Studies on 8-methoxypsoralen tolbutamide interactions. 2. Studies after U.V.-A irradiation in vitro and in vivo. Bevilacqua R; Baccichetti F Farmaco; 1991 Dec; 46(12):1449-57. PubMed ID: 1821629 [TBL] [Abstract][Full Text] [Related]
2. Studies on 8-methoxypsoralen tolbutamide interactions in vitro and in vivo. Bevilacqua R; Baccichetti F; Gaion RM Farmaco; 1991 Apr; 46(4):579-92. PubMed ID: 1930554 [TBL] [Abstract][Full Text] [Related]
3. Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs. Bevilacqua R; Benassi CA; Schiavon O; Veronese FM Farmaco Sci; 1981 Jul; 36(7):598-605. PubMed ID: 7274442 [TBL] [Abstract][Full Text] [Related]
4. A new aspect of serum protein binding of tolbutamide. Ayanoğlu G; Uihlein M; Grigoleit HG Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):65-8. PubMed ID: 3957494 [TBL] [Abstract][Full Text] [Related]
5. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Dufour EK; Kumaravel T; Nohynek GJ; Kirkland D; Toutain H Mutat Res; 2006 Sep; 607(2):215-24. PubMed ID: 16797222 [TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light. Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471 [TBL] [Abstract][Full Text] [Related]
7. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters. Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684 [TBL] [Abstract][Full Text] [Related]
8. The binding of 8-methoxypsoralen by human serum albumin. Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G Farmaco Sci; 1978 Sep; 33(9):667-75. PubMed ID: 744263 [TBL] [Abstract][Full Text] [Related]
9. [The effect of monochromatic and polychromatic UV irradiation and of 8-MOP on phagocytosis of neutrophilic granulocytes]. Schaarschmidt H; Müller MB; Walther T; Rytter M; Knopf B; Gast W Dermatol Monatsschr; 1990; 176(8):475-81. PubMed ID: 2227060 [TBL] [Abstract][Full Text] [Related]
10. In vivo photochemical skin micronucleus test using a sunlight simulator: detection of 8-methoxypsoralen and benzo[a]pyrene in hairless mice. Hara T; Nishikawa T; Sui H; Kawakami K; Matsumoto H; Tanaka N Mutat Res; 2007 Jul; 631(1):1-8. PubMed ID: 17512241 [TBL] [Abstract][Full Text] [Related]
11. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment. Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539 [TBL] [Abstract][Full Text] [Related]
12. Effect of UV-B erythema of psoralen, trimethylpsoralen, and 8 methoxypsoralen. Coupez L; Agache PG; Petigny M Acta Derm Venereol; 1980; 60(5):456-9. PubMed ID: 6162327 [TBL] [Abstract][Full Text] [Related]
13. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study. Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892 [TBL] [Abstract][Full Text] [Related]
14. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen. Man I; Dawe RS; Ferguson J; Ibbotson SH Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888 [TBL] [Abstract][Full Text] [Related]
15. Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestations. Lerman S Natl Cancer Inst Monogr; 1984 Dec; 66():227-33. PubMed ID: 6531035 [TBL] [Abstract][Full Text] [Related]
16. Protecting the eye from ultraviolet A radiation during photochemotherapy. Deleu H; Roelandts R Photodermatol Photoimmunol Photomed; 1990 Dec; 7(6):233-6. PubMed ID: 2103130 [TBL] [Abstract][Full Text] [Related]
17. [8-methoxypsoralen serum content of problem patients in PUVA therapy]. Walther T; Haustein UF Dermatol Monatsschr; 1990; 176(5-6):317-21. PubMed ID: 2227049 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides. Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785 [TBL] [Abstract][Full Text] [Related]
19. A new device to study ex-vivo the effects of extracorporeal photochemotherapy on the immune system. Rigolio R; Perseghin P; Jonsson S; Petersson J; Cavaletti G; Cilio CM J Photochem Photobiol B; 2007 Jul; 88(1):68-75. PubMed ID: 17583527 [TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of 8-methoxypsoralen and long-wave ultraviolet irradiation in V-79 Chinese hamster cells. A first approach to a risk estimate in photochemotherapy. Burger PM; Simons JW Mutat Res; 1979 May; 60(3):381-9. PubMed ID: 481433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]